+19,380.1%
DINO vs GSK
+1,705.8%
+17,674.3%
-86.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -1.9% | +1.2% | -0.3% |
| 7D | +5.7% | -1.8% | +7.5% | +6.1% |
| 30D | +27.8% | -2.2% | +30.0% | +28.3% |
| 3M | +45.6% | -1.8% | +47.4% | +45.8% |
| 6M | +88.5% | -10.6% | +99.1% | +91.7% |
| YTD | +134.1% | +4.4% | +129.7% | +129.2% |
| 1Y | +111.1% | +30.4% | +80.7% | +95.7% |
| 3Y | +109.1% | +60.1% | +49.0% | +81.9% |
| 5Y | +307.2% | +46.8% | +260.4% | +258.4% |
| 10Y | +495.9% | +79.2% | +416.7% | +400.3% |
| All | +19,380.1% | +1,705.8% | +17,674.3% | +12,772.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling